Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

NCT07868861 is registered in ClinicalTrials.gov with Nasus Pharma as lead sponsor.

NCT NCT07868861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07868861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
Lead sponsor
Nasus Pharma
Phase
Phase 1
Overall status
Recruiting
Start date
September 15, 2026
Completion date
February 28, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting (cinv), postoperative nausea and vomiting, radiotherapy-induced nausea and vomiting (rinv)